ROIVRoivant Sciences Ltd.
- Market cap
- $26.36B
- as of 2026-10-23
- Latest close
- $36.49
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Biotechnology
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2023-10-02
Showing the latest 500 of 690 transactions.
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Venker EricPresident & Immunovant CEO | Oct 20 | Oct 22 | S | 185,856 | $35.09 | Sale −$6,521,687 | 1,413,298 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Oct 20 | Oct 22 | S | 14,144 | $35.42 | Sale −$500,980 | 1,399,154 | Yes | Form 4 |
| Sukhatme MayukhPresident & CIO | Oct 16 | Oct 20 | F | 19,976 | $33.53 | $669,795 | 18,563,884 | No | Form 4 |
| Gline MatthewCEO | Oct 16 | Oct 20 | F | 34,638 | $33.53 | $1,161,412 | 16,549,136 | No | Form 4 |
| Epperly Melissa B, | Oct 1 | Oct 5 | M | 17,750 | $4.46 | $79,165 | 32,704 | Yes | Form 4 |
| Epperly Melissa B, | Oct 1 | Oct 5 | S | 16,850 | $36.08 | Sale −$607,948 | 15,854 | Yes | Form 4 |
| Epperly Melissa B, | Oct 1 | Oct 5 | S | 900 | $36.57 | Sale −$32,913 | 14,954 | Yes | Form 4 |
| Epperly Melissa B, | Oct 1 | Oct 5 | M · derivative | 17,750 | $4.46 | $79,165 | 151,416 | Yes | Form 4 |
| Sukhatme MayukhPresident & CIO | Sep 30 | Oct 2 | F | 46,879 | $36.57 | $1,714,365 | 18,583,860 | No | Form 4 |
| Venker EricPresident & Immunovant CEO | Sep 30 | Oct 2 | M | 200,000 | $3.85 | $770,000 | 1,799,154 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Sep 30 | Oct 2 | S | 200,000 | $36.62 | Sale −$7,324,000 | 1,599,154 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Sep 30 | Oct 2 | M · derivative | 200,000 | $3.85 | $770,000 | 3,644,834 | Yes | Form 4 |
| Torti FrankPresident and Vant Chair | Sep 30 | Oct 2 | F | 40,309 | $36.57 | $1,474,100 | 13,495,893 | No | Form 4 |
| Gline MatthewCEO | Sep 30 | Oct 2 | F | 76,171 | $36.57 | $2,785,573 | 16,583,774 | No | Form 4 |
| Humes JenniferChief Accounting Officer | Sep 20 | Sep 22 | F | 3,880 | $39.77 | $154,308 | 106,419 | No | Form 4 |
| Pulik RichardCFO | Sep 20 | Sep 22 | F | 2,129 | $39.77 | $84,670 | 269,681 | No | Form 4 |
| Manchester Keith S | Sep 16 | Sep 18 | A | 5,054 | $0.00 | $0 | 1,753,457 | No | Form 4 |
| Manchester Keith S | Sep 16 | Sep 18 | A · derivative | 10,531 | $39.57 | $416,712 | 10,531 | No | Form 4 |
| Momtazee James C | Sep 16 | Sep 18 | A | 5,054 | $0.00 | $0 | 111,959 | No | Form 4 |
| Momtazee James C | Sep 16 | Sep 18 | A · derivative | 10,531 | $39.57 | $416,712 | 10,531 | No | Form 4 |
| Fitzgerald Meghan | Sep 16 | Sep 18 | A | 5,054 | $0.00 | $0 | 41,162 | No | Form 4 |
| Fitzgerald Meghan | Sep 16 | Sep 18 | A · derivative | 10,531 | $39.57 | $416,712 | 10,531 | No | Form 4 |
| Oren Ilan | Sep 16 | Sep 18 | A | 5,054 | $0.00 | $0 | 123,680 | No | Form 4 |
| Oren Ilan | Sep 16 | Sep 18 | A · derivative | 10,531 | $39.57 | $416,712 | 10,531 | No | Form 4 |
| Gold Daniel Allen | Sep 16 | Sep 18 | A | 5,054 | $0.00 | $0 | 8,965,815 | No | Form 4 |
| Gold Daniel Allen | Sep 16 | Sep 18 | A · derivative | 10,531 | $39.57 | $416,712 | 10,531 | No | Form 4 |
| Epperly Melissa B, | Sep 16 | Sep 18 | A | 5,054 | $0.00 | $0 | 14,954 | No | Form 4 |
| Epperly Melissa B, | Sep 16 | Sep 18 | A · derivative | 10,531 | $39.57 | $416,712 | 10,531 | No | Form 4 |
| Fitzgerald Meghan | Sep 15 | Sep 17 | S | 4,712 | $39.68 | Sale −$186,972 | 36,508 | Yes | Form 4 |
| Fitzgerald Meghan | Sep 15 | Sep 17 | S | 400 | $40.45 | Sale −$16,180 | 36,108 | Yes | Form 4 |
| Epperly Melissa B, | Sep 15 | Sep 17 | S | 4,338 | $39.65 | Sale −$172,002 | 10,500 | Yes | Form 4 |
| Epperly Melissa B, | Sep 15 | Sep 17 | S | 600 | $40.38 | Sale −$24,228 | 9,900 | Yes | Form 4 |
| Gold Daniel Allen | Sep 10 | Sep 14 | F | 5,133 | $40.94 | $210,145 | 8,960,761 | No | Form 4 |
| Momtazee James C | Sep 10 | Sep 14 | F | 2,905 | $40.94 | $118,931 | 106,905 | No | Form 4 |
| Fitzgerald Meghan | Sep 10 | Sep 14 | F | 1,743 | $40.94 | $71,358 | 41,220 | No | Form 4 |
| Oren Ilan | Sep 10 | Sep 14 | F | 2,378 | $40.94 | $97,355 | 118,626 | No | Form 4 |
| Epperly Melissa B, | Sep 10 | Sep 14 | F | 2,179 | $40.94 | $89,208 | 14,838 | No | Form 4 |
| Fitzgerald Meghan | Sep 8 | Sep 10 | M | 20,000 | $8.80 | $176,000 | 62,963 | Yes | Form 4 |
| Fitzgerald Meghan | Sep 8 | Sep 10 | S | 20,000 | $39.90 | Sale −$798,000 | 42,963 | Yes | Form 4 |
| Fitzgerald Meghan | Sep 8 | Sep 10 | M · derivative | 20,000 | $8.80 | $176,000 | 18,578 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Aug 28 | Sep 1 | M | 200,000 | $3.85 | $770,000 | 1,799,154 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Aug 28 | Sep 1 | S | 166,182 | $35.63 | Sale −$5,921,065 | 1,632,972 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Aug 28 | Sep 1 | S | 33,818 | $36.44 | Sale −$1,232,328 | 1,599,154 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Aug 28 | Sep 1 | M · derivative | 200,000 | $3.85 | $770,000 | 3,844,834 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Aug 20 | Aug 24 | F | 13,909 | $36.84 | $512,408 | 1,599,154 | No | Form 4 |
| Pulik RichardCFO | Aug 20 | Aug 24 | F | 5,749 | $36.84 | $211,793 | 271,810 | No | Form 4 |
| Sukhatme MayukhPresident & CIO | Aug 21 | Aug 21 | M | 144,756 | $3.85 | $557,311 | 18,775,495 | No | Form 4 |
| Sukhatme MayukhPresident & CIO | Aug 21 | Aug 21 | S | 144,756 | $36.48 | Sale −$5,280,699 | 18,630,739 | No | Form 4 |
| Sukhatme MayukhPresident & CIO | Aug 21 | Aug 21 | M · derivative | 144,756 | $3.85 | $557,311 | 13,224,363 | No | Form 4 |
| Sukhatme MayukhPresident & CIO | Aug 20 | Aug 21 | M | 17,519 | $3.85 | $67,448 | 18,648,258 | No | Form 4 |
| Sukhatme MayukhPresident & CIO | Aug 20 | Aug 21 | S | 17,519 | $37.30 | Sale −$653,459 | 18,630,739 | No | Form 4 |
| Sukhatme MayukhPresident & CIO | Aug 20 | Aug 21 | M · derivative | 17,519 | $3.85 | $67,448 | 13,369,119 | No | Form 4 |
| Sukhatme MayukhPresident & CIO | Aug 19 | Aug 21 | M | 172,899 | $3.85 | $665,661 | 18,803,638 | No | Form 4 |
| Sukhatme MayukhPresident & CIO | Aug 19 | Aug 21 | S | 172,899 | $37.17 | Sale −$6,426,656 | 18,630,739 | No | Form 4 |
| Sukhatme MayukhPresident & CIO | Aug 19 | Aug 21 | M · derivative | 172,899 | $3.85 | $665,661 | 13,386,638 | No | Form 4 |
| Sukhatme MayukhPresident & CIO | Aug 18 | Aug 18 | M | 105,141 | $3.85 | $404,793 | 18,735,880 | No | Form 4 |
| Sukhatme MayukhPresident & CIO | Aug 18 | Aug 18 | S | 105,141 | $36.59 | Sale −$3,847,109 | 18,630,739 | No | Form 4 |
| Sukhatme MayukhPresident & CIO | Aug 18 | Aug 18 | M | 31,801 | $3.85 | $122,434 | 18,662,540 | No | Form 4 |
| Sukhatme MayukhPresident & CIO | Aug 18 | Aug 18 | S | 31,801 | $37.18 | Sale −$1,182,361 | 18,630,739 | No | Form 4 |
| Sukhatme MayukhPresident & CIO | Aug 18 | Aug 18 | M · derivative | 136,942 | $3.85 | $527,227 | 13,559,537 | No | Form 4 |
| Sukhatme MayukhPresident & CIO | Aug 17 | Aug 18 | M | 284,707 | $3.85 | $1,096,122 | 18,915,446 | No | Form 4 |
| Sukhatme MayukhPresident & CIO | Aug 17 | Aug 18 | S | 284,707 | $36.25 | Sale −$10,320,629 | 18,630,739 | No | Form 4 |
| Sukhatme MayukhPresident & CIO | Aug 17 | Aug 18 | M · derivative | 284,707 | $3.85 | $1,096,122 | 13,696,479 | No | Form 4 |
| Sukhatme MayukhPresident & CIO | Aug 14 | Aug 18 | M | 243,177 | $3.85 | $936,231 | 18,873,916 | No | Form 4 |
| Sukhatme MayukhPresident & CIO | Aug 14 | Aug 18 | S | 243,177 | $36.23 | Sale −$8,810,303 | 18,630,739 | No | Form 4 |
| Sukhatme MayukhPresident & CIO | Aug 14 | Aug 18 | M · derivative | 243,177 | $3.85 | $936,231 | 13,981,186 | No | Form 4 |
| Venker EricPresident & Immunovant CEO | Jul 27 | Jul 29 | M | 200,000 | $3.85 | $770,000 | 1,813,063 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Jul 27 | Jul 29 | S | 200,000 | $34.95 | Sale −$6,990,000 | 1,613,063 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Jul 27 | Jul 29 | M · derivative | 200,000 | $3.85 | $770,000 | 4,044,834 | Yes | Form 4 |
| Oren Ilan | Jul 17 | Jul 21 | A | 775 | $0.00 | $0 | 121,004 | No | Form 4 |
| Epperly Melissa B, | Jul 17 | Jul 21 | A | 543 | $0.00 | $0 | 17,017 | No | Form 4 |
| Momtazee James C | Jul 17 | Jul 21 | A | 405 | $0.00 | $0 | 109,810 | No | Form 4 |
| Fitzgerald Meghan | Jun 30 | Jul 2 | M | 10,000 | $8.80 | $88,000 | 52,963 | Yes | Form 4 |
| Fitzgerald Meghan | Jun 30 | Jul 2 | S | 10,000 | $34.90 | Sale −$349,000 | 42,963 | Yes | Form 4 |
| Fitzgerald Meghan | Jun 30 | Jul 2 | M · derivative | 10,000 | $8.80 | $88,000 | 38,578 | Yes | Form 4 |
| Sukhatme MayukhPresident & CIO | Jun 30 | Jul 2 | F | 46,878 | $35.39 | $1,659,012 | 18,630,739 | No | Form 4 |
| Torti FrankPresident and Vant Chair | Jun 30 | Jul 2 | F | 40,310 | $35.39 | $1,426,571 | 13,536,202 | No | Form 4 |
| Gline MatthewCEO | Jun 30 | Jul 2 | F | 76,171 | $35.39 | $2,695,692 | 16,659,945 | No | Form 4 |
| Epperly Melissa B, | Jun 29 | Jul 1 | M | 17,750 | $4.46 | $79,165 | 34,224 | Yes | Form 4 |
| Epperly Melissa B, | Jun 29 | Jul 1 | S | 15,002 | $34.32 | Sale −$514,869 | 19,222 | Yes | Form 4 |
| Epperly Melissa B, | Jun 29 | Jul 1 | S | 2,748 | $34.71 | Sale −$95,383 | 16,474 | Yes | Form 4 |
| Epperly Melissa B, | Jun 29 | Jul 1 | M · derivative | 17,750 | $4.46 | $79,165 | 169,166 | Yes | Form 4 |
| QVT Financial LP | Jun 30 | Jun 30 | S | 12,380 | $35.28 | Sale −$436,766 | 13,689,166 | No | Form 4 |
| Gold Daniel Allen | Jun 30 | Jun 30 | S | 12,380 | $35.28 | Sale −$436,766 | 13,689,166 | No | Form 4 |
| Manchester Keith S | Jun 30 | Jun 30 | S | 12,380 | $35.28 | Sale −$436,766 | 13,689,166 | No | Form 4 |
| Manchester Keith S | Jun 30 | Jun 30 | S | 200,000 | $35.45 | Sale −$7,090,000 | 1,748,403 | No | Form 4 |
| QVT Financial LP | Jun 29 | Jun 30 | S | 200,000 | $34.44 | Sale −$6,888,000 | 14,301,546 | No | Form 4 |
| QVT Financial LP | Jun 29 | Jun 30 | S | 600,000 | $34.59 | Sale −$20,754,000 | 13,701,546 | No | Form 4 |
| Gold Daniel Allen | Jun 29 | Jun 30 | S | 200,000 | $34.44 | Sale −$6,888,000 | 14,301,546 | No | Form 4 |
| Gold Daniel Allen | Jun 29 | Jun 30 | S | 600,000 | $34.59 | Sale −$20,754,000 | 13,701,546 | No | Form 4 |
| Manchester Keith S | Jun 29 | Jun 30 | S | 200,000 | $34.44 | Sale −$6,888,000 | 14,301,546 | No | Form 4 |
| Manchester Keith S | Jun 29 | Jun 30 | S | 600,000 | $34.59 | Sale −$20,754,000 | 13,701,546 | No | Form 4 |
| QVT Financial LP | Jun 26 | Jun 30 | S | 300,783 | $33.92 | Sale −$10,202,559 | 14,826,546 | No | Form 4 |
| QVT Financial LP | Jun 26 | Jun 30 | S | 325,000 | $34.07 | Sale −$11,072,750 | 14,501,546 | No | Form 4 |
| Gold Daniel Allen | Jun 26 | Jun 30 | S | 300,783 | $33.92 | Sale −$10,202,559 | 14,826,546 | No | Form 4 |
| Gold Daniel Allen | Jun 26 | Jun 30 | S | 325,000 | $34.07 | Sale −$11,072,750 | 14,501,546 | No | Form 4 |
| Manchester Keith S | Jun 26 | Jun 30 | S | 300,783 | $33.92 | Sale −$10,202,559 | 14,826,546 | No | Form 4 |
| Manchester Keith S | Jun 26 | Jun 30 | S | 325,000 | $34.07 | Sale −$11,072,750 | 14,501,546 | No | Form 4 |
| Sukhatme MayukhPresident & CIO | Jun 26 | Jun 29 | M | 500,000 | $3.85 | $1,925,000 | 19,177,617 | No | Form 4 |
| Sukhatme MayukhPresident & CIO | Jun 26 | Jun 29 | S | 500,000 | $34.08 | Sale −$17,040,000 | 18,677,617 | No | Form 4 |
| Sukhatme MayukhPresident & CIO | Jun 26 | Jun 29 | M · derivative | 500,000 | $3.85 | $1,925,000 | 14,224,363 | No | Form 4 |
| Sukhatme MayukhPresident & CIO | Jun 25 | Jun 29 | M | 500,000 | $3.85 | $1,925,000 | 19,177,617 | No | Form 4 |
| Sukhatme MayukhPresident & CIO | Jun 25 | Jun 29 | S | 500,000 | $34.13 | Sale −$17,065,000 | 18,677,617 | No | Form 4 |
| Sukhatme MayukhPresident & CIO | Jun 25 | Jun 29 | M · derivative | 500,000 | $3.85 | $1,925,000 | 14,724,363 | No | Form 4 |
| Venker EricPresident & Immunovant CEO | Jun 24 | Jun 26 | M | 200,000 | $3.85 | $770,000 | 1,813,063 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Jun 24 | Jun 26 | S | 153,766 | $33.05 | Sale −$5,081,966 | 1,659,297 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Jun 24 | Jun 26 | S | 46,234 | $33.51 | Sale −$1,549,301 | 1,613,063 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Jun 24 | Jun 26 | M · derivative | 200,000 | $3.85 | $770,000 | 4,244,834 | Yes | Form 4 |
| Humes JenniferChief Accounting Officer | Jun 20 | Jun 23 | F | 3,582 | $31.43 | $112,582 | 109,782 | No | Form 4 |
| Pulik RichardCFO | Jun 20 | Jun 23 | F | 2,129 | $31.43 | $66,914 | 276,420 | No | Form 4 |
| Venker EricPresident & Immunovant CEO | May 22 | May 22 | M | 200,000 | $3.85 | $770,000 | 1,813,063 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | May 22 | May 22 | S | 200,000 | $30.27 | Sale −$6,054,000 | 1,613,063 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | May 22 | May 22 | M · derivative | 200,000 | $3.85 | $770,000 | 4,444,834 | Yes | Form 4 |
| Pulik RichardCFO | May 20 | May 22 | F | 18,962 | $32.41 | $614,558 | 278,549 | No | Form 4 |
| Venker EricPresident & Immunovant CEO | May 20 | May 22 | F | 34,483 | $32.41 | $1,117,594 | 1,613,063 | Yes | Form 4 |
| Humes JenniferChief Accounting Officer | Apr 20 | Apr 22 | A | 29,173 | $0.00 | $0 | 113,364 | No | Form 4 |
| Humes JenniferChief Accounting Officer | Apr 20 | Apr 22 | A · derivative | 27,157 | $29.08 | $789,726 | 27,157 | No | Form 4 |
| Pulik RichardCFO | Apr 20 | Apr 22 | A | 60,644 | $0.00 | $0 | 297,511 | No | Form 4 |
| Pulik RichardCFO | Apr 20 | Apr 22 | A · derivative | 84,026 | $29.08 | $2,443,476 | 84,026 | No | Form 4 |
| Venker EricPresident & Immunovant CEO | Apr 20 | Apr 22 | M | 200,000 | $3.85 | $770,000 | 1,847,546 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Apr 20 | Apr 22 | S | 200,000 | $29.59 | Sale −$5,918,000 | 1,647,546 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Apr 20 | Apr 22 | M · derivative | 200,000 | $3.85 | $770,000 | 4,644,834 | Yes | Form 4 |
| Oren Ilan | Apr 17 | Apr 21 | A | 896 | $0.00 | $0 | 120,324 | No | Form 4 |
| Oren Ilan | Apr 17 | Apr 21 | F | 95 | $29.83 | $2,834 | 120,229 | No | Form 4 |
| Momtazee James C | Apr 17 | Apr 21 | A | 469 | $0.00 | $0 | 109,499 | No | Form 4 |
| Momtazee James C | Apr 17 | Apr 21 | F | 94 | $29.83 | $2,804 | 109,405 | No | Form 4 |
| Epperly Melissa B, | Apr 17 | Apr 21 | A | 670 | $0.00 | $0 | 16,474 | No | Form 4 |
| Gline MatthewCEO | Apr 16 | Apr 20 | S | 289,774 | $29.16 | Sale −$8,449,810 | 16,736,116 | No | Form 4 |
| Humes JenniferChief Accounting Officer | Apr 8 | Apr 10 | S | 13,538 | $28.37 | Sale −$384,073 | 84,191 | No | Form 4 |
| Torti FrankPresident and Vant Chair | Mar 31 | Apr 2 | F | 160,035 | $27.70 | $4,432,970 | 13,576,512 | No | Form 4 |
| Sukhatme MayukhPresident & CIO | Mar 31 | Apr 1 | F | 187,512 | $27.70 | $5,194,082 | 18,677,617 | No | Form 4 |
| Gline MatthewCEO | Mar 31 | Apr 1 | F | 304,684 | $27.70 | $8,439,747 | 17,025,890 | No | Form 4 |
| Sukhatme MayukhPresident & CIO | Mar 30 | Apr 1 | M | 58,391 | not reported | not reported | 18,894,938 | No | Form 4 |
| Sukhatme MayukhPresident & CIO | Mar 30 | Apr 1 | F | 29,809 | $26.41 | $787,256 | 18,865,129 | No | Form 4 |
| Sukhatme MayukhPresident & CIO | Mar 30 | Apr 1 | M · derivative | 1,306,889 | $11.50 | $15,029,224 | not reported | No | Form 4 |
| Gline MatthewCEO | Mar 30 | Apr 1 | M | 97,319 | not reported | not reported | 17,384,400 | No | Form 4 |
| Gline MatthewCEO | Mar 30 | Apr 1 | F | 53,826 | $26.41 | $1,421,545 | 17,330,574 | No | Form 4 |
| Gline MatthewCEO | Mar 30 | Apr 1 | M · derivative | 2,178,150 | $11.50 | $25,048,725 | not reported | No | Form 4 |
| Fitzgerald Meghan | Mar 26 | Mar 30 | M | 70,000 | $8.80 | $616,000 | 112,963 | No | Form 4 |
| Fitzgerald Meghan | Mar 26 | Mar 30 | S | 70,000 | $27.45 | Sale −$1,921,500 | 42,963 | No | Form 4 |
| Fitzgerald Meghan | Mar 26 | Mar 30 | M · derivative | 70,000 | $8.80 | $616,000 | 48,578 | No | Form 4 |
| Humes JenniferChief Accounting Officer | Mar 20 | Mar 24 | F | 14,526 | $27.70 | $402,370 | 97,729 | No | Form 4 |
| Pulik RichardCFO | Mar 20 | Mar 24 | F | 1,546 | $27.70 | $42,824 | 236,867 | No | Form 4 |
| Venker EricPresident & Immunovant CEO | Mar 17 | Mar 19 | M | 200,000 | $3.85 | $770,000 | 1,847,546 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Mar 17 | Mar 19 | S | 200,000 | $28.24 | Sale −$5,648,000 | 1,647,546 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Mar 17 | Mar 19 | M · derivative | 200,000 | $3.85 | $770,000 | 4,844,834 | Yes | Form 4 |
| Epperly Melissa B, | Mar 16 | Mar 18 | S | 41,861 | $28.68 | Sale −$1,200,573 | 15,804 | No | Form 4 |
| Venker EricPresident & Immunovant CEO | Feb 20 | Feb 24 | F | 7,051 | $27.15 | $191,435 | 1,647,546 | No | Form 4 |
| Pulik RichardCFO | Feb 20 | Feb 24 | F | 1,000 | $27.15 | $27,150 | 238,413 | No | Form 4 |
| Torti FrankPresident and Vant Chair | Feb 23 | Feb 23 | M | 587,390 | $3.85 | $2,261,452 | 14,323,937 | Yes | Form 4 |
| Torti FrankPresident and Vant Chair | Feb 23 | Feb 23 | S | 587,390 | $27.51 | Sale −$16,159,099 | 13,736,547 | Yes | Form 4 |
| Torti FrankPresident and Vant Chair | Feb 23 | Feb 23 | M · derivative | 587,390 | $3.85 | $2,261,452 | 3,026,184 | Yes | Form 4 |
| Torti FrankPresident and Vant Chair | Feb 20 | Feb 23 | M | 1,012,610 | $3.85 | $3,898,549 | 14,749,157 | Yes | Form 4 |
| Torti FrankPresident and Vant Chair | Feb 20 | Feb 23 | S | 1,012,610 | $27.15 | Sale −$27,492,362 | 13,736,547 | Yes | Form 4 |
| Torti FrankPresident and Vant Chair | Feb 20 | Feb 23 | M · derivative | 1,012,610 | $3.85 | $3,898,549 | 3,613,574 | Yes | Form 4 |
| Torti FrankPresident and Vant Chair | Feb 19 | Feb 23 | M | 1,400,000 | $3.85 | $5,390,000 | 15,136,547 | Yes | Form 4 |
| Torti FrankPresident and Vant Chair | Feb 19 | Feb 23 | S | 1,400,000 | $27.42 | Sale −$38,388,000 | 13,736,547 | Yes | Form 4 |
| Torti FrankPresident and Vant Chair | Feb 19 | Feb 23 | M · derivative | 1,400,000 | $3.85 | $5,390,000 | 4,626,184 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Feb 13 | Feb 18 | M | 200,000 | $3.85 | $770,000 | 1,854,597 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Feb 13 | Feb 18 | S | 200,000 | $26.49 | Sale −$5,298,000 | 1,654,597 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Feb 13 | Feb 18 | M · derivative | 200,000 | $3.85 | $770,000 | 5,044,834 | Yes | Form 4 |
| QVT Financial LP | Feb 13 | Feb 13 | S | 150,784 | $26.49 | Sale −$3,994,268 | 15,352,329 | No | Form 4 |
| QVT Financial LP | Feb 13 | Feb 13 | S | 225,000 | $26.50 | Sale −$5,962,500 | 15,127,329 | No | Form 4 |
| Gold Daniel Allen | Feb 13 | Feb 13 | S | 150,784 | $26.49 | Sale −$3,994,268 | 15,352,329 | No | Form 4 |
| Gold Daniel Allen | Feb 13 | Feb 13 | S | 225,000 | $26.50 | Sale −$5,962,500 | 15,127,329 | No | Form 4 |
| Manchester Keith S | Feb 13 | Feb 13 | S | 150,784 | $26.49 | Sale −$3,994,268 | 15,352,329 | No | Form 4 |
| Manchester Keith S | Feb 13 | Feb 13 | S | 225,000 | $26.50 | Sale −$5,962,500 | 15,127,329 | No | Form 4 |
| QVT Financial LP | Feb 12 | Feb 13 | S | 150,000 | $26.72 | Sale −$4,008,000 | 15,778,113 | No | Form 4 |
| QVT Financial LP | Feb 12 | Feb 13 | S | 275,000 | $26.76 | Sale −$7,359,000 | 15,503,113 | No | Form 4 |
| Gold Daniel Allen | Feb 12 | Feb 13 | S | 150,000 | $26.72 | Sale −$4,008,000 | 15,778,113 | No | Form 4 |
| Gold Daniel Allen | Feb 12 | Feb 13 | S | 275,000 | $26.76 | Sale −$7,359,000 | 15,503,113 | No | Form 4 |
| Manchester Keith S | Feb 12 | Feb 13 | S | 150,000 | $26.72 | Sale −$4,008,000 | 15,778,113 | No | Form 4 |
| Manchester Keith S | Feb 12 | Feb 13 | S | 275,000 | $26.76 | Sale −$7,359,000 | 15,503,113 | No | Form 4 |
| QVT Financial LP | Feb 11 | Feb 13 | S | 425,000 | $26.67 | Sale −$11,334,750 | 15,928,113 | No | Form 4 |
| Gold Daniel Allen | Feb 11 | Feb 13 | S | 425,000 | $26.67 | Sale −$11,334,750 | 15,928,113 | No | Form 4 |
| Manchester Keith S | Feb 11 | Feb 13 | S | 425,000 | $26.67 | Sale −$11,334,750 | 15,928,113 | No | Form 4 |
| Sukhatme MayukhPresident & CIO | Feb 9 | Feb 11 | M | 651,558 | $12.68 | $8,261,755 | 19,488,105 | No | Form 4 |
| Sukhatme MayukhPresident & CIO | Feb 9 | Feb 11 | S | 339,441 | $26.47 | Sale −$8,985,003 | 19,148,664 | No | Form 4 |
| Sukhatme MayukhPresident & CIO | Feb 9 | Feb 11 | J | 312,117 | $26.47 | $8,261,737 | 18,836,547 | No | Form 4 |
| Sukhatme MayukhPresident & CIO | Feb 9 | Feb 11 | M · derivative | 651,558 | $12.68 | $8,261,755 | not reported | No | Form 4 |
| Epperly Melissa B, | Jan 20 | Jan 22 | A | 815 | $0.00 | $0 | 57,719 | No | Form 4 |
| Epperly Melissa B, | Jan 20 | Jan 22 | F | 54 | $22.98 | $1,241 | 57,665 | No | Form 4 |
| Oren Ilan | Jan 20 | Jan 22 | A | 1,164 | $0.00 | $0 | 119,552 | No | Form 4 |
| Oren Ilan | Jan 20 | Jan 22 | F | 124 | $22.98 | $2,850 | 119,428 | No | Form 4 |
| Momtazee James C | Jan 20 | Jan 22 | A | 609 | $0.00 | $0 | 109,152 | No | Form 4 |
| Momtazee James C | Jan 20 | Jan 22 | F | 122 | $22.98 | $2,804 | 109,030 | No | Form 4 |
| Venker EricPresident & Immunovant CEO | Jan 12 | Jan 14 | M | 200,000 | $3.85 | $770,000 | 1,854,597 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Jan 12 | Jan 14 | S | 200,000 | $21.92 | Sale −$4,384,000 | 1,654,597 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Jan 12 | Jan 14 | M · derivative | 200,000 | $3.85 | $770,000 | 5,244,834 | Yes | Form 4 |
| Sukhatme MayukhPresident & CIO | Dec 31, 2025 | Dec 31, 2025 | M | 2,449,877 | $12.68 | $31,064,440 | 21,286,424 | No | Form 4 |
| Sukhatme MayukhPresident & CIO | Dec 31, 2025 | Dec 31, 2025 | S | 1,018,995 | $21.71 | Sale −$22,122,381 | 20,267,429 | No | Form 4 |
| Sukhatme MayukhPresident & CIO | Dec 31, 2025 | Dec 31, 2025 | J | 1,430,882 | $21.71 | $31,064,448 | 18,836,547 | No | Form 4 |
| Sukhatme MayukhPresident & CIO | Dec 31, 2025 | Dec 31, 2025 | M · derivative | 2,449,877 | $12.68 | $31,064,440 | 95,718 | No | Form 4 |
| Sukhatme MayukhPresident & CIO | Dec 29, 2025 | Dec 31, 2025 | M | 748,358 | $12.68 | $9,489,179 | 19,584,905 | No | Form 4 |
| Sukhatme MayukhPresident & CIO | Dec 29, 2025 | Dec 31, 2025 | S | 311,873 | $21.74 | Sale −$6,780,119 | 19,273,032 | No | Form 4 |
| Sukhatme MayukhPresident & CIO | Dec 29, 2025 | Dec 31, 2025 | J | 436,485 | $21.74 | $9,489,184 | 18,836,547 | No | Form 4 |
| Sukhatme MayukhPresident & CIO | Dec 29, 2025 | Dec 31, 2025 | M · derivative | 748,358 | $12.68 | $9,489,179 | 555,840 | No | Form 4 |
| Venker EricPresident & Immunovant CEO | Dec 24, 2025 | Dec 29, 2025 | M | 117,848 | $3.85 | $453,715 | 1,729,597 | No | Form 4 |
| Venker EricPresident & Immunovant CEO | Dec 24, 2025 | Dec 29, 2025 | S | 75,000 | $22.53 | Sale −$1,689,750 | 1,654,597 | No | Form 4 |
| Venker EricPresident & Immunovant CEO | Dec 24, 2025 | Dec 29, 2025 | M · derivative | 117,848 | $3.85 | $453,715 | 5,444,834 | No | Form 4 |
| Torti FrankPresident and Vant Chair | Dec 24, 2025 | Dec 29, 2025 | J | 64,891 | $22.47 | $1,458,101 | 13,847,036 | No | Form 4 |
| Torti FrankPresident and Vant Chair | Dec 24, 2025 | Dec 29, 2025 | G | 110,489 | $0.00 | $0 | 13,736,547 | No | Form 4 |
| Venker EricPresident & Immunovant CEO | Dec 23, 2025 | Dec 29, 2025 | M | 313,841 | $3.85 | $1,208,288 | 1,811,749 | No | Form 4 |
| Venker EricPresident & Immunovant CEO | Dec 23, 2025 | Dec 29, 2025 | S | 200,000 | $22.45 | Sale −$4,490,000 | 1,611,749 | No | Form 4 |
| Venker EricPresident & Immunovant CEO | Dec 23, 2025 | Dec 29, 2025 | M · derivative | 313,841 | $3.85 | $1,208,288 | 5,562,682 | No | Form 4 |
| Pulik RichardCFO | Dec 23, 2025 | Dec 29, 2025 | M | 260,000 | $3.85 | $1,001,000 | 646,144 | No | Form 4 |
| Pulik RichardCFO | Dec 23, 2025 | Dec 29, 2025 | S | 260,000 | $22.45 | Sale −$5,837,000 | 386,144 | No | Form 4 |
| Pulik RichardCFO | Dec 23, 2025 | Dec 29, 2025 | S | 146,731 | $22.39 | Sale −$3,285,307 | 239,413 | No | Form 4 |
| Pulik RichardCFO | Dec 23, 2025 | Dec 29, 2025 | M · derivative | 260,000 | $3.85 | $1,001,000 | 740,000 | No | Form 4 |
| Torti FrankPresident and Vant Chair | Dec 23, 2025 | Dec 29, 2025 | A | 175,380 | $22.45 | $3,937,281 | 13,911,927 | No | Form 4 |
| Pulik RichardCFO | Dec 20, 2025 | Dec 23, 2025 | F | 2,129 | $22.41 | $47,711 | 386,144 | No | Form 4 |
| Sukhatme MayukhPresident & CIO | Dec 17, 2025 | Dec 19, 2025 | M | 59,513 | $12.68 | $754,625 | 18,896,060 | No | Form 4 |
| Sukhatme MayukhPresident & CIO | Dec 17, 2025 | Dec 19, 2025 | S | 26,831 | $23.09 | Sale −$619,528 | 18,869,229 | No | Form 4 |
| Sukhatme MayukhPresident & CIO | Dec 17, 2025 | Dec 19, 2025 | J | 32,682 | $23.09 | $754,627 | 18,836,547 | No | Form 4 |
| Sukhatme MayukhPresident & CIO | Dec 17, 2025 | Dec 19, 2025 | M · derivative | 59,513 | $12.68 | $754,625 | 1,304,198 | No | Form 4 |
| QVT Financial LP | Dec 17, 2025 | Dec 18, 2025 | S | 432,718 | $23.05 | Sale −$9,974,150 | 16,697,727 | No | Form 4 |
| QVT Financial LP | Dec 17, 2025 | Dec 18, 2025 | S | 155,076 | $23.02 | Sale −$3,569,850 | 16,542,651 | No | Form 4 |
| QVT Financial LP | Dec 17, 2025 | Dec 18, 2025 | S | 189,538 | $23.17 | Sale −$4,391,595 | 16,353,113 | No | Form 4 |
| Manchester Keith S | Dec 17, 2025 | Dec 18, 2025 | S | 432,718 | $23.05 | Sale −$9,974,150 | 16,697,727 | No | Form 4 |
| Manchester Keith S | Dec 17, 2025 | Dec 18, 2025 | S | 155,076 | $23.02 | Sale −$3,569,850 | 16,542,651 | No | Form 4 |
| Manchester Keith S | Dec 17, 2025 | Dec 18, 2025 | S | 189,538 | $23.17 | Sale −$4,391,595 | 16,353,113 | No | Form 4 |
| Gold Daniel Allen | Dec 17, 2025 | Dec 18, 2025 | S | 432,718 | $23.05 | Sale −$9,974,150 | 16,697,727 | No | Form 4 |
| Gold Daniel Allen | Dec 17, 2025 | Dec 18, 2025 | S | 155,076 | $23.02 | Sale −$3,569,850 | 16,542,651 | No | Form 4 |
| Gold Daniel Allen | Dec 17, 2025 | Dec 18, 2025 | S | 189,538 | $23.17 | Sale −$4,391,595 | 16,353,113 | No | Form 4 |
| QVT Financial LP | Dec 16, 2025 | Dec 18, 2025 | S | 275,000 | $22.93 | Sale −$6,305,750 | 17,772,727 | No | Form 4 |
| QVT Financial LP | Dec 16, 2025 | Dec 18, 2025 | S | 642,282 | $23.08 | Sale −$14,823,869 | 17,130,445 | No | Form 4 |
| Manchester Keith S | Dec 16, 2025 | Dec 18, 2025 | S | 275,000 | $22.93 | Sale −$6,305,750 | 17,772,727 | No | Form 4 |
| Manchester Keith S | Dec 16, 2025 | Dec 18, 2025 | S | 642,282 | $23.08 | Sale −$14,823,869 | 17,130,445 | No | Form 4 |
| Gold Daniel Allen | Dec 16, 2025 | Dec 18, 2025 | S | 275,000 | $22.93 | Sale −$6,305,750 | 17,772,727 | No | Form 4 |
| Gold Daniel Allen | Dec 16, 2025 | Dec 18, 2025 | S | 642,282 | $23.08 | Sale −$14,823,869 | 17,130,445 | No | Form 4 |
| Gline MatthewCEO | Dec 15, 2025 | Dec 17, 2025 | M | 234,096 | $4.06 | $950,430 | 17,521,177 | No | Form 4 |
| Gline MatthewCEO | Dec 15, 2025 | Dec 17, 2025 | S | 230,357 | $21.68 | Sale −$4,994,140 | 17,290,820 | No | Form 4 |
| Gline MatthewCEO | Dec 15, 2025 | Dec 17, 2025 | J | 3,739 | $21.68 | $81,062 | 17,287,081 | No | Form 4 |
| Gline MatthewCEO | Dec 15, 2025 | Dec 17, 2025 | M | 1,363,711 | $12.68 | $17,291,855 | 18,650,792 | No | Form 4 |
| Gline MatthewCEO | Dec 15, 2025 | Dec 17, 2025 | S | 566,116 | $21.68 | Sale −$12,273,395 | 18,084,676 | No | Form 4 |
| Gline MatthewCEO | Dec 15, 2025 | Dec 17, 2025 | J | 797,595 | $21.68 | $17,291,860 | 17,287,081 | No | Form 4 |
| Gline MatthewCEO | Dec 15, 2025 | Dec 17, 2025 | M | 2,272,852 | $12.68 | $28,819,763 | 19,559,933 | No | Form 4 |
| Gline MatthewCEO | Dec 15, 2025 | Dec 17, 2025 | S | 943,527 | $21.68 | Sale −$20,455,665 | 18,616,406 | No | Form 4 |
| Gline MatthewCEO | Dec 15, 2025 | Dec 17, 2025 | J | 1,329,325 | $21.68 | $28,819,766 | 17,287,081 | No | Form 4 |
| Gline MatthewCEO | Dec 15, 2025 | Dec 17, 2025 | M · derivative | 234,096 | $4.06 | $950,430 | not reported | No | Form 4 |
| Gline MatthewCEO | Dec 15, 2025 | Dec 17, 2025 | M · derivative | 1,363,711 | $12.68 | $17,291,855 | not reported | No | Form 4 |
| Gline MatthewCEO | Dec 15, 2025 | Dec 17, 2025 | M · derivative | 2,272,852 | $12.68 | $28,819,763 | not reported | No | Form 4 |
| Ramaswamy Vivek | Dec 15, 2025 | Dec 15, 2025 | M | 832,453 | $12.68 | $10,555,504 | 34,486,208 | No | Form 4 |
| Ramaswamy Vivek | Dec 15, 2025 | Dec 15, 2025 | S | 353,745 | $22.05 | Sale −$7,800,077 | 34,132,463 | No | Form 4 |
| Ramaswamy Vivek | Dec 15, 2025 | Dec 15, 2025 | J | 478,708 | $22.05 | $10,555,511 | 33,653,755 | No | Form 4 |
| Ramaswamy Vivek | Dec 15, 2025 | Dec 15, 2025 | M · derivative | 832,453 | $12.68 | $10,555,504 | 22,150,227 | No | Form 4 |
| Ramaswamy Vivek | Dec 12, 2025 | Dec 15, 2025 | M | 4,672,724 | $12.68 | $59,250,140 | 38,326,479 | No | Form 4 |
| Ramaswamy Vivek | Dec 12, 2025 | Dec 15, 2025 | S | 1,975,858 | $21.96 | Sale −$43,389,842 | 36,350,621 | No | Form 4 |
| Ramaswamy Vivek | Dec 12, 2025 | Dec 15, 2025 | J | 2,696,866 | $21.96 | $59,223,177 | 33,653,755 | No | Form 4 |
| Ramaswamy Vivek | Dec 12, 2025 | Dec 15, 2025 | M · derivative | 4,672,724 | $12.68 | $59,250,140 | 22,982,680 | No | Form 4 |
| Ramaswamy Vivek | Dec 11, 2025 | Dec 15, 2025 | M | 1,869,691 | $12.68 | $23,707,682 | 35,523,447 | No | Form 4 |
| Ramaswamy Vivek | Dec 11, 2025 | Dec 15, 2025 | S | 774,142 | $21.64 | Sale −$16,752,433 | 34,749,305 | No | Form 4 |
| Ramaswamy Vivek | Dec 11, 2025 | Dec 15, 2025 | J | 1,095,550 | $21.64 | $23,707,702 | 33,653,755 | No | Form 4 |
| Ramaswamy Vivek | Dec 11, 2025 | Dec 15, 2025 | M · derivative | 1,869,691 | $12.68 | $23,707,682 | 27,655,404 | No | Form 4 |
| Venker EricPresident & Immunovant CEO | Dec 9, 2025 | Dec 11, 2025 | M | 200,000 | $3.85 | $770,000 | 1,697,908 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Dec 9, 2025 | Dec 11, 2025 | S | 200,000 | $20.85 | Sale −$4,170,000 | 1,497,908 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Dec 9, 2025 | Dec 11, 2025 | M · derivative | 200,000 | $3.85 | $770,000 | 5,876,523 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Nov 20, 2025 | Nov 24, 2025 | F | 7,051 | $20.27 | $142,924 | 1,497,908 | No | Form 4 |
| Pulik RichardCFO | Nov 20, 2025 | Nov 24, 2025 | F | 1,235 | $20.27 | $25,033 | 388,273 | No | Form 4 |
| QVT Financial LP | Nov 19, 2025 | Nov 21, 2025 | S | 850,000 | $20.25 | Sale −$17,212,500 | 18,497,727 | No | Form 4 |
| QVT Financial LP | Nov 19, 2025 | Nov 21, 2025 | S | 150,000 | $20.20 | Sale −$3,030,000 | 18,347,727 | No | Form 4 |
| QVT Financial LP | Nov 19, 2025 | Nov 21, 2025 | S | 125,000 | $20.16 | Sale −$2,520,000 | 18,222,727 | No | Form 4 |
| QVT Financial LP | Nov 19, 2025 | Nov 21, 2025 | S | 175,000 | $20.24 | Sale −$3,542,000 | 18,047,727 | No | Form 4 |
| Gold Daniel Allen | Nov 19, 2025 | Nov 21, 2025 | S | 850,000 | $20.25 | Sale −$17,212,500 | 18,497,727 | No | Form 4 |
| Gold Daniel Allen | Nov 19, 2025 | Nov 21, 2025 | S | 150,000 | $20.20 | Sale −$3,030,000 | 18,347,727 | No | Form 4 |
| Gold Daniel Allen | Nov 19, 2025 | Nov 21, 2025 | S | 125,000 | $20.16 | Sale −$2,520,000 | 18,222,727 | No | Form 4 |
| Gold Daniel Allen | Nov 19, 2025 | Nov 21, 2025 | S | 175,000 | $20.24 | Sale −$3,542,000 | 18,047,727 | No | Form 4 |
| Manchester Keith S | Nov 19, 2025 | Nov 21, 2025 | S | 850,000 | $20.25 | Sale −$17,212,500 | 18,497,727 | No | Form 4 |
| Manchester Keith S | Nov 19, 2025 | Nov 21, 2025 | S | 150,000 | $20.20 | Sale −$3,030,000 | 18,347,727 | No | Form 4 |
| Manchester Keith S | Nov 19, 2025 | Nov 21, 2025 | S | 125,000 | $20.16 | Sale −$2,520,000 | 18,222,727 | No | Form 4 |
| Manchester Keith S | Nov 19, 2025 | Nov 21, 2025 | S | 175,000 | $20.24 | Sale −$3,542,000 | 18,047,727 | No | Form 4 |
| Ramaswamy Vivek | Nov 17, 2025 | Nov 17, 2025 | S | 539,650 | $20.51 | Sale −$11,068,222 | 33,653,756 | No | Form 4 |
| Ramaswamy Vivek | Nov 14, 2025 | Nov 17, 2025 | S | 1,027,670 | $20.33 | Sale −$20,892,531 | 34,193,406 | No | Form 4 |
| Ramaswamy Vivek | Nov 13, 2025 | Nov 17, 2025 | S | 287,283 | $20.81 | Sale −$5,978,359 | 35,221,076 | No | Form 4 |
| Venker EricPresident & Immunovant CEO | Nov 7, 2025 | Nov 7, 2025 | M | 200,000 | $3.85 | $770,000 | 1,704,959 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Nov 7, 2025 | Nov 7, 2025 | S | 200,000 | $20.22 | Sale −$4,044,000 | 1,504,959 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Nov 7, 2025 | Nov 7, 2025 | M · derivative | 200,000 | $20.22 | $4,044,000 | 6,076,523 | Yes | Form 4 |
| Oren Ilan | Oct 20, 2025 | Oct 22, 2025 | A | 1,507 | $0.00 | $0 | 118,669 | No | Form 4 |
| Oren Ilan | Oct 20, 2025 | Oct 22, 2025 | F | 281 | $17.74 | $4,985 | 118,388 | No | Form 4 |
| Momtazee James C | Oct 20, 2025 | Oct 22, 2025 | A | 789 | $0.00 | $0 | 108,701 | No | Form 4 |
| Momtazee James C | Oct 20, 2025 | Oct 22, 2025 | F | 158 | $17.74 | $2,803 | 108,543 | No | Form 4 |
| Epperly Melissa B, | Oct 20, 2025 | Oct 22, 2025 | A | 1,056 | $0.00 | $0 | 56,904 | No | Form 4 |
| Venker EricPresident & Immunovant CEO | Oct 17, 2025 | Oct 17, 2025 | M | 118,418 | $15.85 | $1,876,925 | 1,623,377 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Oct 17, 2025 | Oct 17, 2025 | S | 118,418 | $17.06 | Sale −$2,020,211 | 1,504,959 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Oct 17, 2025 | Oct 17, 2025 | M · derivative | 118,418 | $15.85 | $1,876,925 | not reported | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Oct 16, 2025 | Oct 17, 2025 | M | 318,282 | $15.85 | $5,044,770 | 1,823,241 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Oct 16, 2025 | Oct 17, 2025 | S | 318,282 | $17.05 | Sale −$5,426,708 | 1,504,959 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Oct 16, 2025 | Oct 17, 2025 | M · derivative | 318,282 | $15.85 | $5,044,770 | 118,418 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Oct 15, 2025 | Oct 17, 2025 | M | 414,683 | $15.85 | $6,572,726 | 1,919,642 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Oct 15, 2025 | Oct 17, 2025 | S | 414,683 | $16.93 | Sale −$7,020,583 | 1,504,959 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Oct 15, 2025 | Oct 17, 2025 | M · derivative | 414,683 | $15.85 | $6,572,726 | 436,700 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Oct 13, 2025 | Oct 14, 2025 | M | 20,727 | $15.85 | $328,523 | 1,525,686 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Oct 13, 2025 | Oct 14, 2025 | S | 20,727 | $16.25 | Sale −$336,814 | 1,504,959 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Oct 13, 2025 | Oct 14, 2025 | M · derivative | 20,727 | $15.85 | $328,523 | 851,383 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Oct 9, 2025 | Oct 14, 2025 | M | 104,940 | $15.85 | $1,663,299 | 1,609,899 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Oct 9, 2025 | Oct 14, 2025 | S | 104,940 | $16.30 | Sale −$1,710,522 | 1,504,959 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Oct 9, 2025 | Oct 14, 2025 | M · derivative | 104,940 | $15.85 | $1,663,299 | 872,110 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Oct 8, 2025 | Oct 8, 2025 | M | 10,307 | $15.85 | $163,366 | 1,515,266 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Oct 8, 2025 | Oct 8, 2025 | M | 128,295 | $7.45 | $955,798 | 1,643,561 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Oct 8, 2025 | Oct 8, 2025 | S | 138,602 | $16.20 | Sale −$2,245,352 | 1,504,959 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Oct 8, 2025 | Oct 8, 2025 | M · derivative | 10,307 | $15.85 | $163,366 | 977,050 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Oct 8, 2025 | Oct 8, 2025 | M · derivative | 128,295 | $7.45 | $955,798 | not reported | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Oct 7, 2025 | Oct 8, 2025 | M | 67,171 | $15.85 | $1,064,660 | 1,572,130 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Oct 7, 2025 | Oct 8, 2025 | M | 107,131 | $7.45 | $798,126 | 1,679,261 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Oct 7, 2025 | Oct 8, 2025 | M | 180,859 | $3.85 | $696,307 | 1,860,120 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Oct 7, 2025 | Oct 8, 2025 | S | 355,161 | $16.15 | Sale −$5,735,850 | 1,504,959 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Oct 7, 2025 | Oct 8, 2025 | M · derivative | 67,171 | $15.85 | $1,064,660 | 987,357 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Oct 7, 2025 | Oct 8, 2025 | M · derivative | 107,131 | $7.45 | $798,126 | 128,295 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Oct 7, 2025 | Oct 8, 2025 | M · derivative | 180,859 | $3.85 | $696,307 | 6,276,523 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Oct 6, 2025 | Oct 8, 2025 | M | 127,355 | $15.85 | $2,018,577 | 1,632,314 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Oct 6, 2025 | Oct 8, 2025 | M | 24,900 | $7.45 | $185,505 | 1,657,214 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Oct 6, 2025 | Oct 8, 2025 | M | 19,141 | $3.85 | $73,693 | 1,676,355 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Oct 6, 2025 | Oct 8, 2025 | S | 171,396 | $16.34 | Sale −$2,800,611 | 1,504,959 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Oct 6, 2025 | Oct 8, 2025 | M · derivative | 127,355 | $15.85 | $2,018,577 | 1,054,528 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Oct 6, 2025 | Oct 8, 2025 | M · derivative | 24,900 | $7.45 | $185,505 | 235,426 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Oct 6, 2025 | Oct 8, 2025 | M · derivative | 19,141 | $3.85 | $73,693 | 6,457,382 | Yes | Form 4 |
| Pulik RichardCFO | Sep 28, 2025 | Sep 30, 2025 | F | 2,341 | $15.17 | $35,513 | 389,508 | No | Form 4 |
| Venker EricPresident & Immunovant CEO | Sep 23, 2025 | Sep 23, 2025 | S | 611,000 | $14.83 | Sale −$9,061,130 | 1,504,959 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Sep 22, 2025 | Sep 23, 2025 | M | 462,374 | $3.85 | $1,780,140 | 2,432,141 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Sep 22, 2025 | Sep 23, 2025 | M | 100,000 | $3.85 | $385,000 | 2,532,141 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Sep 22, 2025 | Sep 23, 2025 | S | 316,182 | $14.99 | Sale −$4,739,568 | 2,215,959 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Sep 22, 2025 | Sep 23, 2025 | S | 100,000 | $15.01 | Sale −$1,501,000 | 2,115,959 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Sep 22, 2025 | Sep 23, 2025 | M · derivative | 462,374 | $3.85 | $1,780,140 | 6,576,523 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Sep 22, 2025 | Sep 23, 2025 | M · derivative | 100,000 | $3.85 | $385,000 | 6,476,523 | Yes | Form 4 |
| Pulik RichardCFO | Sep 20, 2025 | Sep 23, 2025 | F | 2,129 | $15.04 | $32,020 | 391,849 | No | Form 4 |
| Venker EricPresident & Immunovant CEO | Sep 19, 2025 | Sep 23, 2025 | M | 1,000,000 | $3.85 | $3,850,000 | 2,653,585 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Sep 19, 2025 | Sep 23, 2025 | S | 683,818 | $14.95 | Sale −$10,223,079 | 1,969,767 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Sep 19, 2025 | Sep 23, 2025 | M · derivative | 1,000,000 | $3.85 | $3,850,000 | 7,038,897 | Yes | Form 4 |
| Gline MatthewCEO | Sep 18, 2025 | Sep 18, 2025 | P | 3,315 | $15.07 | Purchase +$49,957 | 17,287,081 | No | Form 4 |
| Epperly Melissa B, | Sep 10, 2025 | Sep 12, 2025 | A | 14,524 | $0.00 | $0 | 57,509 | No | Form 4 |
| Epperly Melissa B, | Sep 10, 2025 | Sep 12, 2025 | J | 1,661 | $13.77 | $22,872 | 55,848 | No | Form 4 |
| Epperly Melissa B, | Sep 10, 2025 | Sep 12, 2025 | A · derivative | 33,726 | $13.77 | $464,407 | 33,726 | No | Form 4 |
| Momtazee James C | Sep 10, 2025 | Sep 12, 2025 | A | 14,524 | $0.00 | $0 | 111,194 | No | Form 4 |
| Momtazee James C | Sep 10, 2025 | Sep 12, 2025 | J | 3,282 | $13.77 | $45,193 | 107,912 | No | Form 4 |
| Momtazee James C | Sep 10, 2025 | Sep 12, 2025 | A · derivative | 33,726 | $13.77 | $464,407 | 33,726 | No | Form 4 |
| Oren Ilan | Sep 10, 2025 | Sep 12, 2025 | A | 14,524 | $0.00 | $0 | 119,205 | No | Form 4 |
| Oren Ilan | Sep 10, 2025 | Sep 12, 2025 | J | 2,043 | $13.77 | $28,132 | 117,162 | No | Form 4 |
| Oren Ilan | Sep 10, 2025 | Sep 12, 2025 | A · derivative | 33,726 | $13.77 | $464,407 | 33,726 | No | Form 4 |
| Fitzgerald Meghan | Sep 10, 2025 | Sep 12, 2025 | A | 14,524 | $0.00 | $0 | 43,900 | No | Form 4 |
| Fitzgerald Meghan | Sep 10, 2025 | Sep 12, 2025 | J | 937 | $13.77 | $12,902 | 42,963 | No | Form 4 |
| Fitzgerald Meghan | Sep 10, 2025 | Sep 12, 2025 | A · derivative | 33,726 | $13.77 | $464,407 | 33,726 | No | Form 4 |
| Gold Daniel Allen | Sep 10, 2025 | Sep 12, 2025 | A | 14,524 | $0.00 | $0 | 8,971,164 | No | Form 4 |
| Gold Daniel Allen | Sep 10, 2025 | Sep 12, 2025 | J | 5,270 | $13.77 | $72,568 | 8,965,894 | No | Form 4 |
| Gold Daniel Allen | Sep 10, 2025 | Sep 12, 2025 | A · derivative | 33,726 | $13.77 | $464,407 | 33,726 | No | Form 4 |
| Manchester Keith S | Sep 10, 2025 | Sep 12, 2025 | A | 14,524 | $0.00 | $0 | 1,948,403 | No | Form 4 |
| Manchester Keith S | Sep 10, 2025 | Sep 12, 2025 | A · derivative | 33,726 | $13.77 | $464,407 | 33,726 | No | Form 4 |
| Ramaswamy Vivek | Sep 5, 2025 | Sep 5, 2025 | S | 385,816 | $12.96 | Sale −$5,000,175 | 35,508,359 | No | Form 4 |
| Ramaswamy Vivek | Sep 4, 2025 | Sep 5, 2025 | S | 194,933 | $12.92 | Sale −$2,518,534 | 35,894,175 | No | Form 4 |
| Ramaswamy Vivek | Sep 3, 2025 | Sep 5, 2025 | S | 1,195,000 | $12.50 | Sale −$14,937,500 | 36,089,108 | No | Form 4 |
| Pulik RichardCFO | Aug 28, 2025 | Sep 2, 2025 | F | 2,340 | $11.94 | $27,940 | 393,978 | No | Form 4 |
| Venker EricPresident & Immunovant CEO | Aug 20, 2025 | Aug 22, 2025 | F | 7,051 | $11.72 | $82,638 | 1,653,585 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Aug 20, 2025 | Aug 22, 2025 | M | 100,000 | $3.85 | $385,000 | 1,753,585 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Aug 20, 2025 | Aug 22, 2025 | S | 100,000 | $11.72 | Sale −$1,172,000 | 1,653,585 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Aug 20, 2025 | Aug 22, 2025 | M · derivative | 100,000 | $3.85 | $385,000 | 8,038,897 | Yes | Form 4 |
| Pulik RichardCFO | Aug 20, 2025 | Aug 22, 2025 | F | 1,235 | $11.72 | $14,474 | 396,318 | No | Form 4 |
| Venker EricPresident & Immunovant CEO | Jul 30, 2025 | Aug 1, 2025 | A | 198,413 | $0.00 | $0 | 1,660,636 | No | Form 4 |
| Torti FrankPresident and Vant Chair | Jul 30, 2025 | Aug 1, 2025 | A | 1,836,547 | $0.00 | $0 | 1,836,547 | No | Form 4 |
| Torti FrankPresident and Vant Chair | Jul 30, 2025 | Aug 1, 2025 | A | 11,900,000 | $0.00 | $0 | 13,736,547 | No | Form 4 |
| Pulik RichardCFO | Jul 28, 2025 | Jul 30, 2025 | F | 1,919 | $11.35 | $21,781 | 397,553 | No | Form 4 |
| Venker EricPresident & Immunovant CEO | Jul 21, 2025 | Jul 23, 2025 | M | 100,000 | $3.85 | $385,000 | 1,562,223 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Jul 21, 2025 | Jul 23, 2025 | S | 100,000 | $11.52 | Sale −$1,152,000 | 1,462,223 | Yes | Form 4 |
| Venker EricPresident & Immunovant CEO | Jul 21, 2025 | Jul 23, 2025 | M · derivative | 100,000 | $3.85 | $385,000 | 8,138,897 | Yes | Form 4 |
| Epperly Melissa B, | Jul 17, 2025 | Jul 21, 2025 | A | 1,609 | $0.00 | $0 | 42,985 | No | Form 4 |
| Momtazee James C | Jul 17, 2025 | Jul 21, 2025 | A | 1,201 | $0.00 | $0 | 96,911 | No | Form 4 |
| Momtazee James C | Jul 17, 2025 | Jul 21, 2025 | F | 241 | $11.65 | $2,808 | 96,670 | No | Form 4 |
| Oren Ilan | Apr 17, 2025 | Jul 21, 2025 | A | 2,296 | $0.00 | $0 | 104,796 | No | Form 4 |
| Oren Ilan | Apr 17, 2025 | Jul 21, 2025 | F | 115 | $11.65 | $1,340 | 104,681 | No | Form 4 |
| Pulik RichardCFO | Jun 28, 2025 | Jul 1, 2025 | F | 1,653 | $11.39 | $18,828 | 399,472 | No | Form 4 |
| QVT Financial LP | Jun 25, 2025 | Jun 27, 2025 | J | 55,443 | $0.00 | $0 | not reported | No | Form 4 |
| QVT Financial LP | Jun 25, 2025 | Jun 27, 2025 | J | 6,205,368 | $0.00 | $0 | 8,441,428 | No | Form 4 |
| QVT Financial LP | Jun 25, 2025 | Jun 27, 2025 | J | 3,176,245 | $0.00 | $0 | 19,347,727 | No | Form 4 |
| QVT Financial LP | Jun 25, 2025 | Jun 27, 2025 | J | 19,311,790 | $0.00 | $0 | not reported | No | Form 4 |
| QVT Financial LP | Jun 25, 2025 | Jun 27, 2025 | J | 6,837,266 | $0.00 | $0 | not reported | No | Form 4 |
| QVT Financial LP | Jun 25, 2025 | Jun 27, 2025 | J | 1,170,646 | $0.00 | $0 | 1,592,480 | No | Form 4 |
| Manchester Keith S | Jun 25, 2025 | Jun 27, 2025 | J | 6,205,368 | $0.00 | $0 | 8,441,428 | No | Form 4 |
| Manchester Keith S | Jun 25, 2025 | Jun 27, 2025 | J | 3,176,245 | $0.00 | $0 | 19,347,727 | No | Form 4 |
| Manchester Keith S | Jun 25, 2025 | Jun 27, 2025 | J | 6,837,266 | $0.00 | $0 | not reported | No | Form 4 |
| Manchester Keith S | Jun 25, 2025 | Jun 27, 2025 | J | 1,170,646 | $0.00 | $0 | 1,592,480 | No | Form 4 |
| Gold Daniel Allen | Jun 25, 2025 | Jun 27, 2025 | J | 19,311,790 | $0.00 | $0 | not reported | No | Form 4 |
| Gold Daniel Allen | Jun 25, 2025 | Jun 27, 2025 | J | 6,837,266 | $0.00 | $0 | not reported | No | Form 4 |
| Gold Daniel Allen | Jun 25, 2025 | Jun 27, 2025 | J | 55,443 | $0.00 | $0 | not reported | No | Form 4 |
| Gold Daniel Allen | Jun 25, 2025 | Jun 27, 2025 | J | 1,170,646 | $0.00 | $0 | 1,592,480 | No | Form 4 |
| Gold Daniel Allen | Jun 25, 2025 | Jun 27, 2025 | J | 6,205,368 | $0.00 | $0 | 8,441,428 | No | Form 4 |
| Gold Daniel Allen | Jun 25, 2025 | Jun 27, 2025 | J | 3,176,245 | $0.00 | $0 | 19,347,727 | No | Form 4 |
| Venker EricPresident & COO | Jun 20, 2025 | Jun 24, 2025 | M | 100,000 | $3.85 | $385,000 | 1,562,223 | Yes | Form 4 |
| Venker EricPresident & COO | Jun 20, 2025 | Jun 24, 2025 | S | 100,000 | $11.45 | Sale −$1,145,000 | 1,462,223 | Yes | Form 4 |
| Venker EricPresident & COO | Jun 20, 2025 | Jun 24, 2025 | M · derivative | 100,000 | $3.85 | $385,000 | 8,238,897 | Yes | Form 4 |
| Pulik RichardCFO | Jun 20, 2025 | Jun 24, 2025 | F | 1,503 | $11.45 | $17,209 | 399,056 | No | Form 4 |
| Ramaswamy Vivek | Jun 20, 2025 | Jun 23, 2025 | S | 577,007 | $11.46 | Sale −$6,612,500 | 37,284,108 | No | Form 4 |
| Ramaswamy Vivek | Jun 18, 2025 | Jun 23, 2025 | S | 565,266 | $11.45 | Sale −$6,472,296 | 37,861,115 | No | Form 4 |
| Ramaswamy Vivek | Jun 6, 2025 | Jun 6, 2025 | S | 200,800 | $11.19 | Sale −$2,246,952 | 38,426,381 | No | Form 4 |
| Ramaswamy Vivek | Jun 4, 2025 | Jun 6, 2025 | S | 547,430 | $11.34 | Sale −$6,207,856 | 38,627,181 | No | Form 4 |
| Venker EricPresident & COO | Jun 3, 2025 | Jun 4, 2025 | M | 785,026 | $3.85 | $3,022,350 | 2,028,501 | No | Form 4 |
| Venker EricPresident & COO | Jun 3, 2025 | Jun 4, 2025 | S | 566,278 | $11.22 | Sale −$6,353,639 | 1,462,223 | No | Form 4 |
| Venker EricPresident & COO | Jun 3, 2025 | Jun 4, 2025 | M · derivative | 785,026 | $3.85 | $3,022,350 | 8,338,897 | No | Form 4 |
| Venker EricPresident & COO | Jun 2, 2025 | Jun 4, 2025 | M | 600,000 | $3.85 | $2,310,000 | 1,677,197 | No | Form 4 |
| Venker EricPresident & COO | Jun 2, 2025 | Jun 4, 2025 | S | 433,722 | $11.07 | Sale −$4,801,303 | 1,243,475 | No | Form 4 |
| Venker EricPresident & COO | Jun 2, 2025 | Jun 4, 2025 | M · derivative | 600,000 | $3.85 | $2,310,000 | 9,123,923 | No | Form 4 |
| Pulik RichardCFO | May 28, 2025 | May 30, 2025 | F | 1,653 | $10.62 | $17,555 | 400,559 | No | Form 4 |
| Gline MatthewCEO | May 20, 2025 | May 22, 2025 | F | 10,945 | $11.04 | $120,833 | 17,283,766 | No | Form 4 |
| Venker EricPresident & COO | May 20, 2025 | May 22, 2025 | F | 39,148 | $11.04 | $432,194 | 1,077,197 | Yes | Form 4 |
| Venker EricPresident & COO | May 20, 2025 | May 22, 2025 | M | 100,000 | $3.85 | $385,000 | 1,177,197 | Yes | Form 4 |
| Venker EricPresident & COO | May 20, 2025 | May 22, 2025 | S | 100,000 | $10.95 | Sale −$1,095,000 | 1,077,197 | Yes | Form 4 |
| Venker EricPresident & COO | May 20, 2025 | May 22, 2025 | M · derivative | 100,000 | $3.85 | $385,000 | 9,723,923 | Yes | Form 4 |
| Pulik RichardCFO | May 20, 2025 | May 22, 2025 | F | 3,487 | $11.04 | $38,496 | 402,212 | No | Form 4 |
| Ramaswamy Vivek | May 7, 2025 | May 8, 2025 | S | 625,000 | $11.18 | Sale −$6,987,500 | 39,174,611 | No | Form 4 |
| Ramaswamy Vivek | May 6, 2025 | May 8, 2025 | S | 273,959 | $11.47 | Sale −$3,142,310 | 39,799,611 | No | Form 4 |
| Pulik RichardCFO | Apr 28, 2025 | Apr 30, 2025 | F | 1,653 | $11.19 | $18,497 | 405,699 | No | Form 4 |
| Pulik RichardCFO | Apr 21, 2025 | Apr 23, 2025 | A | 141,464 | $0.00 | $0 | 407,352 | No | Form 4 |
| Pulik RichardCFO | Apr 21, 2025 | Apr 23, 2025 | A · derivative | 180,413 | $10.04 | $1,811,347 | 180,413 | No | Form 4 |
| Venker EricPresident & COO | Apr 21, 2025 | Apr 22, 2025 | M | 100,000 | $3.85 | $385,000 | 1,216,345 | Yes | Form 4 |
| Venker EricPresident & COO | Apr 21, 2025 | Apr 22, 2025 | S | 100,000 | $10.22 | Sale −$1,022,000 | 1,116,345 | Yes | Form 4 |
| Venker EricPresident & COO | Apr 21, 2025 | Apr 22, 2025 | M · derivative | 100,000 | $3.85 | $385,000 | 9,823,923 | Yes | Form 4 |
| Gline MatthewCEO | Apr 20, 2025 | Apr 22, 2025 | F | 10,945 | $10.15 | $111,092 | 17,294,711 | No | Form 4 |
| Venker EricPresident & COO | Apr 20, 2025 | Apr 22, 2025 | F | 10,945 | $10.15 | $111,092 | 1,116,345 | Yes | Form 4 |
| Oren Ilan | Apr 17, 2025 | Apr 21, 2025 | A | 2,635 | $0.00 | $0 | 102,564 | No | Form 4 |
| Oren Ilan | Apr 17, 2025 | Apr 21, 2025 | F | 64 | $10.15 | $650 | 102,500 | No | Form 4 |
| Momtazee James C | Apr 17, 2025 | Apr 21, 2025 | A | 1,379 | $0.00 | $0 | 95,986 | No | Form 4 |
| Momtazee James C | Apr 17, 2025 | Apr 21, 2025 | F | 276 | $10.15 | $2,801 | 95,710 | No | Form 4 |
| Epperly Melissa B, | Apr 17, 2025 | Apr 21, 2025 | A | 1,847 | $0.00 | $0 | 41,376 | No | Form 4 |
| Pulik RichardCFO | Mar 28, 2025 | Apr 1, 2025 | F | 1,653 | $10.38 | $17,158 | 265,888 | No | Form 4 |
| Venker EricPresident & COO | Mar 24, 2025 | Mar 24, 2025 | M | 602,311 | $3.85 | $2,318,897 | 1,561,768 | Yes | Form 4 |
| Venker EricPresident & COO | Mar 24, 2025 | Mar 24, 2025 | S | 434,478 | $10.82 | Sale −$4,701,052 | 1,127,290 | Yes | Form 4 |
| Venker EricPresident & COO | Mar 24, 2025 | Mar 24, 2025 | M · derivative | 602,311 | $3.85 | $2,318,897 | 9,923,923 | Yes | Form 4 |
| Gline MatthewCEO | Mar 20, 2025 | Mar 24, 2025 | F | 10,945 | $10.97 | $120,067 | 17,305,656 | No | Form 4 |
| Pulik RichardCFO | Mar 20, 2025 | Mar 24, 2025 | F | 1,504 | $10.97 | $16,499 | 267,541 | No | Form 4 |
| Humes JenniferChief Accounting Officer | Mar 20, 2025 | Mar 24, 2025 | A | 112,255 | $0.00 | $0 | 112,255 | No | Form 4 |
| Humes JenniferChief Accounting Officer | Mar 20, 2025 | Mar 24, 2025 | A · derivative | 115,108 | $10.97 | $1,262,735 | 115,108 | No | Form 4 |
| Venker EricPresident & COO | Mar 20, 2025 | Mar 24, 2025 | F | 10,945 | $10.97 | $120,067 | 874,979 | Yes | Form 4 |
| Venker EricPresident & COO | Mar 20, 2025 | Mar 24, 2025 | M | 400,000 | $3.85 | $1,540,000 | 1,274,979 | Yes | Form 4 |
| Venker EricPresident & COO | Mar 20, 2025 | Mar 24, 2025 | S | 315,522 | $11.06 | Sale −$3,489,673 | 959,457 | Yes | Form 4 |
| Venker EricPresident & COO | Mar 20, 2025 | Mar 24, 2025 | M · derivative | 400,000 | $3.85 | $1,540,000 | 10,526,234 | Yes | Form 4 |
| Pulik RichardCFO | Feb 28, 2025 | Mar 4, 2025 | F | 1,635 | $10.74 | $17,560 | 269,045 | No | Form 4 |
| Venker EricPresident & COO | Feb 20, 2025 | Feb 24, 2025 | M | 100,000 | $3.85 | $385,000 | 996,869 | No | Form 4 |
| Venker EricPresident & COO | Feb 20, 2025 | Feb 24, 2025 | S | 100,000 | $10.65 | Sale −$1,065,000 | 896,869 | No | Form 4 |
| Venker EricPresident & COO | Feb 20, 2025 | Feb 24, 2025 | F | 10,945 | $10.72 | $117,330 | 885,924 | No | Form 4 |
| Venker EricPresident & COO | Feb 20, 2025 | Feb 24, 2025 | M · derivative | 100,000 | $3.85 | $385,000 | 10,926,234 | No | Form 4 |
| Gline MatthewCEO | Feb 20, 2025 | Feb 24, 2025 | F | 10,945 | $10.72 | $117,330 | 17,316,601 | No | Form 4 |
| Kumar RakhiChief Accounting Officer | Feb 20, 2025 | Feb 24, 2025 | F | 958 | $10.72 | $10,270 | 162,306 | No | Form 4 |
| Kumar RakhiChief Accounting Officer | Feb 13, 2025 | Feb 18, 2025 | M | 187,500 | $3.85 | $721,875 | 390,764 | No | Form 4 |
| Kumar RakhiChief Accounting Officer | Feb 13, 2025 | Feb 18, 2025 | S | 227,500 | $10.43 | Sale −$2,372,825 | 163,264 | No | Form 4 |
| Kumar RakhiChief Accounting Officer | Feb 13, 2025 | Feb 18, 2025 | M · derivative | 187,500 | $3.85 | $721,875 | 312,500 | No | Form 4 |
| Venker EricPresident & COO | Feb 13, 2025 | Feb 14, 2025 | M | 300,000 | $3.85 | $1,155,000 | 1,114,910 | No | Form 4 |
| Venker EricPresident & COO | Feb 13, 2025 | Feb 14, 2025 | S | 218,041 | $10.42 | Sale −$2,271,987 | 896,869 | No | Form 4 |
| Venker EricPresident & COO | Feb 13, 2025 | Feb 14, 2025 | M · derivative | 300,000 | $3.85 | $1,155,000 | 11,026,234 | No | Form 4 |
| Venker EricPresident & COO | Feb 12, 2025 | Feb 14, 2025 | M | 300,000 | $3.85 | $1,155,000 | 1,032,294 | No | Form 4 |
| Venker EricPresident & COO | Feb 12, 2025 | Feb 14, 2025 | S | 217,384 | $10.53 | Sale −$2,289,054 | 732,294 | No | Form 4 |
| Venker EricPresident & COO | Feb 12, 2025 | Feb 14, 2025 | M · derivative | 300,000 | $3.85 | $1,155,000 | 11,326,234 | No | Form 4 |
| Pulik RichardCFO | Jan 28, 2025 | Jan 30, 2025 | F | 1,896 | $11.15 | $21,140 | 270,680 | No | Form 4 |
| Oren Ilan | Jan 23, 2025 | Jan 27, 2025 | A | 2,386 | $0.00 | $0 | 100,242 | No | Form 4 |
| Oren Ilan | Jan 23, 2025 | Jan 27, 2025 | F | 313 | $11.21 | $3,509 | 99,929 | No | Form 4 |
| Momtazee James C | Jan 23, 2025 | Jan 27, 2025 | A | 1,248 | $0.00 | $0 | 94,913 | No | Form 4 |
| Momtazee James C | Jan 23, 2025 | Jan 27, 2025 | F | 306 | $11.21 | $3,430 | 94,607 | No | Form 4 |
| Epperly Melissa B, | Jan 23, 2025 | Jan 27, 2025 | A | 1,672 | $0.00 | $0 | 39,709 | No | Form 4 |
| Epperly Melissa B, | Jan 23, 2025 | Jan 27, 2025 | F | 180 | $11.21 | $2,018 | 39,529 | No | Form 4 |
| Ramaswamy Vivek | Jan 23, 2025 | Jan 27, 2025 | G | 13,357,857 | $0.00 | $0 | 40,073,570 | No | Form 4 |
| Ramaswamy Vivek | Jan 23, 2025 | Jan 27, 2025 | G | 13,357,857 | $0.00 | $0 | 13,357,857 | No | Form 4 |
| Venker EricPresident & COO | Jan 21, 2025 | Jan 22, 2025 | M | 100,000 | $3.85 | $385,000 | 832,294 | Yes | Form 4 |
| Venker EricPresident & COO | Jan 21, 2025 | Jan 22, 2025 | S | 100,000 | $11.28 | Sale −$1,128,000 | 732,294 | Yes | Form 4 |
| Venker EricPresident & COO | Jan 21, 2025 | Jan 22, 2025 | M · derivative | 100,000 | $3.85 | $385,000 | 11,626,234 | Yes | Form 4 |
| Gline MatthewCEO | Jan 20, 2025 | Jan 22, 2025 | F | 11,623 | $11.15 | $129,596 | 17,327,546 | No | Form 4 |
| Venker EricPresident & COO | Jan 20, 2025 | Jan 22, 2025 | F | 8,682 | $11.15 | $96,804 | 732,294 | Yes | Form 4 |
| Kumar RakhiChief Accounting Officer | Jan 20, 2025 | Jan 22, 2025 | F | 1,057 | $11.15 | $11,786 | 203,264 | No | Form 4 |
| Venker EricPresident & COO | Dec 30, 2024 | Dec 31, 2024 | M | 250,000 | $3.85 | $962,500 | 918,680 | No | Form 4 |
| Venker EricPresident & COO | Dec 30, 2024 | Dec 31, 2024 | S | 177,704 | $11.54 | Sale −$2,050,704 | 740,976 | No | Form 4 |
| Venker EricPresident & COO | Dec 30, 2024 | Dec 31, 2024 | M · derivative | 250,000 | $3.85 | $962,500 | 11,726,234 | No | Form 4 |
| Pulik RichardCFO | Dec 28, 2024 | Dec 31, 2024 | F | 1,896 | $11.80 | $22,373 | 272,576 | No | Form 4 |
| Venker EricPresident & COO | Dec 27, 2024 | Dec 31, 2024 | M | 250,000 | $3.85 | $962,500 | 845,580 | No | Form 4 |
| Venker EricPresident & COO | Dec 27, 2024 | Dec 31, 2024 | S | 176,900 | $11.82 | Sale −$2,090,958 | 668,680 | No | Form 4 |
| Venker EricPresident & COO | Dec 27, 2024 | Dec 31, 2024 | M · derivative | 250,000 | $3.85 | $962,500 | 11,976,234 | No | Form 4 |
| Sukhatme MayukhPres&Chief Investment Officer | Dec 26, 2024 | Dec 26, 2024 | M | 689,495 | $3.85 | $2,654,556 | 19,526,042 | No | Form 4 |
| Sukhatme MayukhPres&Chief Investment Officer | Dec 26, 2024 | Dec 26, 2024 | S | 689,495 | $12.01 | Sale −$8,280,835 | 18,836,547 | No | Form 4 |
| Sukhatme MayukhPres&Chief Investment Officer | Dec 26, 2024 | Dec 26, 2024 | M · derivative | 689,495 | $3.85 | $2,654,556 | 15,224,363 | No | Form 4 |
| Sukhatme MayukhPres&Chief Investment Officer | Dec 24, 2024 | Dec 26, 2024 | M | 185,946 | $3.85 | $715,892 | 19,022,493 | No | Form 4 |
| Sukhatme MayukhPres&Chief Investment Officer | Dec 24, 2024 | Dec 26, 2024 | S | 185,946 | $12.00 | Sale −$2,231,352 | 18,836,547 | No | Form 4 |
| Sukhatme MayukhPres&Chief Investment Officer | Dec 24, 2024 | Dec 26, 2024 | M · derivative | 185,946 | $3.85 | $715,892 | 15,913,858 | No | Form 4 |
| Sukhatme MayukhPres&Chief Investment Officer | Dec 23, 2024 | Dec 26, 2024 | M | 10,796 | $3.85 | $41,565 | 18,847,343 | No | Form 4 |
| Sukhatme MayukhPres&Chief Investment Officer | Dec 23, 2024 | Dec 26, 2024 | S | 10,796 | $12.00 | Sale −$129,552 | 18,836,547 | No | Form 4 |
| Sukhatme MayukhPres&Chief Investment Officer | Dec 23, 2024 | Dec 26, 2024 | M · derivative | 10,796 | $3.85 | $41,565 | 16,099,804 | No | Form 4 |
| Gline MatthewCEO | Dec 20, 2024 | Dec 26, 2024 | F | 10,945 | $11.57 | $126,634 | 17,339,169 | No | Form 4 |
| Venker EricPresident & COO | Dec 20, 2024 | Dec 26, 2024 | F | 10,945 | $11.57 | $126,634 | 595,580 | Yes | Form 4 |
| Venker EricPresident & COO | Dec 20, 2024 | Dec 26, 2024 | M | 100,000 | $3.85 | $385,000 | 695,580 | Yes | Form 4 |
| Venker EricPresident & COO | Dec 20, 2024 | Dec 26, 2024 | S | 100,000 | $11.49 | Sale −$1,149,000 | 595,580 | Yes | Form 4 |
| Venker EricPresident & COO | Dec 20, 2024 | Dec 26, 2024 | M · derivative | 100,000 | $3.85 | $385,000 | 12,226,234 | Yes | Form 4 |
| Kumar RakhiChief Accounting Officer | Dec 20, 2024 | Dec 26, 2024 | F | 3,087 | $11.57 | $35,717 | 204,321 | No | Form 4 |
| Pulik RichardCFO | Dec 20, 2024 | Dec 26, 2024 | F | 2,129 | $11.57 | $24,633 | 274,472 | No | Form 4 |
| Sukhatme MayukhPres&Chief Investment Officer | Dec 18, 2024 | Dec 20, 2024 | M | 412,584 | $3.85 | $1,588,448 | 19,249,131 | No | Form 4 |
| Sukhatme MayukhPres&Chief Investment Officer | Dec 18, 2024 | Dec 20, 2024 | S | 412,584 | $12.05 | Sale −$4,971,637 | 18,836,547 | No | Form 4 |
| Sukhatme MayukhPres&Chief Investment Officer | Dec 18, 2024 | Dec 20, 2024 | M · derivative | 412,584 | $3.85 | $1,588,448 | 16,110,600 | No | Form 4 |
| Sukhatme MayukhPres&Chief Investment Officer | Dec 3, 2024 | Dec 5, 2024 | J | 3,651,985 | $12.21 | $44,590,737 | 18,836,547 | No | Form 4 |
| Pulik RichardCFO | Nov 28, 2024 | Dec 2, 2024 | F | 2,341 | $12.69 | $29,707 | 276,601 | No | Form 4 |
| Gline MatthewCEO | Nov 20, 2024 | Nov 22, 2024 | F | 10,945 | $11.49 | $125,758 | 17,350,114 | No | Form 4 |
| Venker EricPresident & COO | Nov 20, 2024 | Nov 22, 2024 | F | 10,945 | $11.49 | $125,758 | 606,525 | Yes | Form 4 |
| Venker EricPresident & COO | Nov 20, 2024 | Nov 22, 2024 | M | 100,000 | $3.85 | $385,000 | 706,525 | Yes | Form 4 |
| Venker EricPresident & COO | Nov 20, 2024 | Nov 22, 2024 | S | 100,000 | $11.32 | Sale −$1,132,000 | 606,525 | Yes | Form 4 |
| Venker EricPresident & COO | Nov 20, 2024 | Nov 22, 2024 | M · derivative | 100,000 | $3.85 | $385,000 | 12,326,234 | Yes | Form 4 |
| Kumar RakhiChief Accounting Officer | Nov 20, 2024 | Nov 22, 2024 | F | 958 | $11.49 | $11,007 | 207,408 | No | Form 4 |
| Pulik RichardCFO | Oct 28, 2024 | Oct 30, 2024 | F | 2,341 | $11.84 | $27,717 | 278,942 | No | Form 4 |
| Oren Ilan | Oct 21, 2024 | Oct 23, 2024 | A | 2,303 | $0.00 | $0 | 97,856 | No | Form 4 |
| Epperly Melissa B, | Oct 21, 2024 | Oct 23, 2024 | A | 1,613 | $0.00 | $0 | 38,037 | No | Form 4 |